Nintedanib in idiopathic pulmonary fibrosis

被引：0
|
作者：
Venkatesan, Priya
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [31] Nintedanib reduced decline in FVC in idiopathic pulmonary fibrosis
    Richeldi, L.
    du Bois, R. M.
    Raghu, G.
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (08)
  • [32] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Yoon, Hee-Young
    Park, Sojung
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2018, 19
  • [33] Population pharmacokinetics of nintedanib in patients with idiopathic pulmonary fibrosis
    Schmid, Ulrike
    Doege, Christiane
    Dallinger, Claudia
    Freiwald, Matthias
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 : 136 - 143
  • [34] NICE guidance on nintedanib for treating idiopathic pulmonary fibrosis
    Laurenson, Sophie
    Sidhu, Raisa
    Goodall, Melinda
    Adler, Amanda I.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (03): : 176 - 177
  • [35] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Azuma, Arata
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    Bando, Masashi
    Abe, Shinji
    Mochizuki, Yoshiro
    Chida, Kingo
    Klueglich, Matthias
    Fujimoto, Tsuyoshi
    Okazaki, Kotaro
    Tadayasu, Yusuke
    Sakamoto, Wataru
    Sugiyama, Yukihiko
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1382 - 1392
  • [36] Evaluation of Perioperative Nintedanib for Lung Cancer with Idiopathic Pulmonary Fibrosis
    Sumiya, R.
    Banno, T.
    Ueno, H.
    Hirayama, S.
    Suzuki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S421 - S421
  • [37] A comparison of pirfenidone versus nintedanib for the management of idiopathic pulmonary fibrosis
    Naqvi, Marium
    D'Ancona, Grainne
    West, Alex
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
    Antonio Rodriguez-Portal, Jose
    DRUGS IN R&D, 2018, 18 (01) : 19 - 25
  • [39] Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis
    Brunnemer, Eva
    Ehlers-Tenenbaum, Svenja
    Heussel, Calus Peter
    Warth, Arne
    Herth, Felix
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [40] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
    Flaherty, Kevin R.
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
12345